Dr. Cindy Prins Assesses Spaces Across UF Campus for COVID-19 Transmission Risks
In her role as the infection preventionist for the UF Health Screen, Test and Protect Program, Cindy Prins, Ph.D., clinical associate professor of epidemiology and assistant dean for educational affairs for the UF College of Public Health and Health Professions, offers infection control assessments for UF entities who aim to resume activities throughout campus.
Plasma Oxalate and Kidney Function Are Correlated in Patients With Primary Hyperoxaluria With Maintained Kidney Function – Data From Three Placebo-Controlled Studies Published
UF startup OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces the publication of an article in Pediatric Nephrology, on the significant correlation between plasma oxalate and kidney function in three controlled clinical trials with PH patients.
UF Researcher Yongpei Guan, Ph.D., Named 2021 IEEE Fellow
Yongpei Guan, Ph.D., a professor in the Department of Industrial & Systems Engineering (ISE) at the University of Florida, has been elevated to Fellow status in The Institute of Electrical and Electronics Engineers (IEEE).
University of Florida Focusing on AI
Researchers with the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) are working as teams to use artificial intelligence (AI) to attack complex issues.
Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board
UF Innovate | The Hub resident client Oxidien Pharmaceuticals announced two additions to its newly organized Strategic Advisory Board (SAB).
AbFero Pharmaceuticals Announces Funding From Cure Parkinson’s for Lead Compound SP-420
AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, announced the award of a grant from Cure Parkinson's for the development of their lead, brain-penetrant iron chelating agent, SP-420, as a disease modifying therapy for Parkinson's disease (PD).
UF Health Jacksonville Is First Site To Test Drug To Prevent Excessive Bleeding
UF Health Jacksonville is the first site in the world to test a new drug designed to prevent excessive bleeding that can occur from taking ticagrelor, a popular blood-thinning medication sold under the brand name Brilinta.
UF Health Virtual Human Intervention Allows for Colorectal Cancer Screening From Home
A new University of Florida Health intervention gives patients who qualify access to colorectal cancer screening information and tests from the comfort of their own homes.
Unsure About the COVID-19 Vaccine? UF Health’s Chief Epidemiologist Has Answers
Nicole M. Iovine, M.D., Ph.D., chief epidemiology officer for the University of Florida Health Shands Hospital system, addresses key issues related to overcoming vaccine hesitancy.
DNAtrix Announces Preclinical Data Demonstrating Anti-Tumor Activity of DNX-2401 in Models of Pediatric Tumors Published in Clinical Cancer Research
UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced preclinical data evaluating the use of DNX-2401 against the pediatric brain malignancies atypical teratoid/rhabdoid tumor (AT/RT) and primitive neuroectodermal tumors (PNETs) was published in Clinical Cancer Research.
